Stoke Therapeutics, Inc. · NASDAQ:STOK

FMR LLC reported a 9.80% stake in Stoke Therapeutics, Inc. (Schedule 13G/A)

Event Dec 31, 2025 · Filed Feb 5, 2026

FMR LLC reported a 9.80% stake in Stoke Therapeutics, Inc., 5,600,920 shares, as a passive investor on Dec 31, 2025. Filed Feb 5, 2026 (Schedule 13G/A).

Stake
9.80%
Shares
5,600,920
Intent
Passive
What changed
Stake changed
Filed together
2 holders

The filing in full

HolderStakeShares
FMR LLC9.80%5,600,920
Abigail P. Johnson9.80%5,600,920

Source

View original at SEC

Related